EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic accuracy and safety of epicutaneous testing in fixed drug eruption

Fabiana Bazanella de Oliveira, Amanda Veiga Cheuiche, Guilherme Ladwig Tejada, Renan Rangel Bonamigo

Anais Brasileiros de Dermatologia · 2026-11 · 101 (6) · 501471

DOI: 10.1016/j.abd.2026.501471 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anais Brasileiros de Dermatologia, 2026-11. Verfasst von Fabiana Bazanella de Oliveira und 3 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto…. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Fixed Drug Eruption (FDE) is a delayed drug reaction in which Oral Provocation Testing (OPT) remains the diagnostic gold standard despite safety and ethical concerns. Skin tests, including Patch Test (PT) and the Repeated Open Application Test (ROAT), may be safer alternatives, but their diagnostic accuracy remains uncertain. OBJECTIVES: To evaluate the diagnostic accuracy and safety of patch testing and ROAT, as complementary tools to OPT, for identifying the culprit drug in FDE. METHODS: Systematic review and meta-analysis followed PRISMA-DTA/2020 guidelines and the PIRD framework. Five databases (MEDLINE, Embase, LILACS, Scopus, and Web of Science) were searched from 1972 to October 2025. Quality was assessed via QUADAS-2 for studies in quantitative synthesis. A bivariate Bayesian random-effects model estimated pooled sensitivity and specificity and generated the Summary Receiver Operating Characteristic (SROC) plot. RESULTS: Seventy-eight studies were included in the qualitative synthesis, comprising 225 paired diagnostic interventions in 145 patients; 25 studies provided data for meta-analysis. Patch testing showed low pooled sensitivity (0.220; 95% CrI 0.060-0.441) and high specificity (0.964; 95% CrI 0.898-0.992), with positive and negative likelihood ratios of 5.98 and 0.81, respectively. Performance was higher on lesional than non-lesional skin (19.2% vs. 5.0%; OR = 7.05, 95% CI 2.03-24.39) and varied by drug class. Safety was favorable, with local reactivation in 2.9% of PT and one systemic reaction. STUDY LIMITATIONS: Evidence was limited by small, mostly descriptive studies, scarce negative controls, absence of immunosuppressed patients in the accuracy dataset, and imprecise ROAT specificity estimates. CONCLUSION: Patch testing and ROAT may aid FDE investigation, particularly when applied to lesional skin, but their low sensitivity limits their rule-out value. They should complement, not replace, OPT until standardized prospective evidence is available. Standardized prospective studies are needed.

Schlagwörter

Stichwörter der Autor:innen

Drug eruptionDrug hypersensitivityImmunologic testsPatch testsSkin testsSystematic review

Autor:innen und Institutionen

  • Postgraduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil. Electronic address: fabibazanella@g…
  • Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Service of Endocrinology, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Service of Dermatology, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, RS, Brazil; Faculty of Medicine, Universidade Feevale, Novo Hamburgo, RS,…
  • Postgraduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; Service of Dermatology, Santa Casa…

Zitieren

APA

de Oliveira, F. B., Cheuiche, A. V., Tejada, G. L., & Bonamigo, R. R. (2026). Diagnostic accuracy and safety of epicutaneous testing in fixed drug eruption. Anais Brasileiros de Dermatologia, 101(6), 501471. https://doi.org/10.1016/j.abd.2026.501471

Vancouver

de Oliveira FB, Cheuiche AV, Tejada GL, Bonamigo RR. Diagnostic accuracy and safety of epicutaneous testing in fixed drug eruption. Anais Brasileiros de Dermatologia. 2026;101(6):501471. doi:10.1016/j.abd.2026.501471

BibTeX
@article{deOliveira2026,
  author = {de Oliveira, Fabiana Bazanella and Cheuiche, Amanda Veiga and Tejada, Guilherme Ladwig and Bonamigo, Renan Rangel},
  title = {Diagnostic accuracy and safety of epicutaneous testing in fixed drug eruption},
  journal = {Anais Brasileiros de Dermatologia},
  year = {2026},
  volume = {101},
  number = {6},
  pages = {501471},
  doi = {10.1016/j.abd.2026.501471}
}
Kostenlos starten →